Residents of Long Island now have access to expanded cancer care with the completion of the full-asset merger of NYU Langone Health with NYU Winthrop Hospital. The merger establishes a number of Perlmutter Cancer Center locations on Long Island, including Perlmutter Cancer Center at NYU Winthrop Hospital, which provides a full range of diagnostic services, treatments, and support programs for all types of cancer. NYU Winthrop Hospital will serve as the site for hospital-based surgical cancer care and the hub for cancer clinical trials on Long Island.

Perlmutter Cancer Center at NYU Winthrop Hospital CyberKnife Center, which offers a noninvasive radiosurgery treatment in which robotic technology is used to deliver targeted radiation therapy, was the first established CyberKnife® center in the region. Surgical oncologists at NYU Winthrop Hospital also specialize in conventional and minimally invasive surgical techniques, including the da Vinci® surgical system, a minimally invasive robotic surgical approach that enables surgeons to make very small incisions and shorten recovery time.

Clinical trials at Perlmutter Cancer Center will be integrated with those of NYU Winthrop Hospital, providing Long Island residents with access to the same cutting-edge treatment options that are available to patients in Manhattan.

The merger enhances an already robust portfolio of existing NYU Langone cancer services on Long Island, including infusion centers in Lake Success and Huntington, staffed by 20 medical oncologists. Plans are actively underway to create multidisciplinary, cancer-specific Disease Management Groups on Long Island  that integrate physicians among Perlmutter Cancer Center’s three infusion centers, including Perlmutter Cancer Center at NYU Winthrop Hospital Infusion Center.

 “We are very excited to have the talented NYU Winthrop faculty and staff join with us to advance cancer research and care,” says Benjamin G. Neel, MD, PhD, professor of medicine and director of Perlmutter Cancer Center. “Having the only National Cancer Institute–designated Comprehensive Cancer Center on Long Island will enable us to provide additional services, advanced treatments, cancer clinical trials, and convenience for Long Island residents.”